Drägerwerk AG & Co. KGaA (DGWPF)
| Market Cap | 1.34B |
| Revenue (ttm) | 3.95B |
| Net Income (ttm) | 117.28M |
| Shares Out | n/a |
| EPS (ttm) | 6.25 |
| PE Ratio | 11.41 |
| Forward PE | 10.61 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Average Volume | 3 |
| Open | 51.00 |
| Previous Close | 57.00 |
| Day's Range | 51.00 - 55.81 |
| 52-Week Range | 45.05 - 57.00 |
| Beta | 0.38 |
| RSI | 99.97 |
| Earnings Date | Jul 29, 2025 |
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departmen... [Read more]
Financial Performance
In 2024, Drägerwerk AG & Co. KGaA's revenue was 3.37 billion, a decrease of -0.08% compared to the previous year's 3.37 billion. Earnings were 124.41 million, an increase of 12.65%.
Financial numbers in EUR Financial StatementsNews
Drägerwerk AG & Co KGaA (DGWPF) Q1 2025 Earnings Call Transcript
Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Q1 2025 Results Conference Call April 30, 2025 8:00 AM ET Company Participants Nikolaus Hammerschmidt - IR Tom Fischler - IR Stefan Dräger - Chief Executive Offic...
Drägerwerk AG & Co KGaA (DGWPF) Full Year 2024 Earnings Call Transcript
Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Full Year 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Stefan Dräger – Chief Executive Officer Gert-Hartwig Lescow – Chief Financi...